JAMMU, MARCH 7: The Directorate of Ayush J&K successfully organized an Awareness Program cum Interactive Session on Rule 170 of the Drugs and Cosmetics Act, 1945 here today, focusing on misleading advertisements and false clai related to Ayush medicines.
The session, held in the Meeting Hall of the Directorate of Ayush, Indra Chowk, was chaired by Director Ayush Dr. Nuzhat Bashir Shah.
The program aimed to sensitize stakeholders about the legal provisions governing Ayush drug advertisements, ensuring compliance with regulation nor to prevent misleading claims that may misguide the public and impact the credibility of the Ayush sector.
Dr Nuzhat Bashir Shah advised the nominated Ayush Medical Officers to act as per Rule 170 and work in close coordination with the Assistant Drug Controllers of their respective districts to enhance regulatory oversight and compliance.
State Drug Controller Lotika Khajuria provided in-depth insights into Rule 170 of the Drugs and Cosmetics Act, elaborating on the legal framework and enforcement mechanics to curb false claim in Ayush drug promotion. She emphasized the need for strict adherence to the Act and urged stakeholders to ensure that advertisements align with the prescribed regulations.
Assistant Director Directorate Ayush Dr Rakesh Kumar Raina provided insights about the role of nominated Ayush Medical Officers under Sub Rule 14 of Rule 170 of Drugs and Cosmetic Rules.
The event was attended by Dr Suresh Sharma Deputy Director Ayush, Jammu, District Ayush Officers, Nominated Ayush Medical Officers representatives from Ayush drug manufacturing units, and other stakeholders, both in person and virtually. The interactive session provided clarity on compliance requirements and best practices for responsible drug promotion in the Ayush sector.
The Directorate of Ayush, J&K, reaffirmed its commitment to ensuring the credibility and authenticity of Ayush medicines by strengthening the regulatory framework and fostering greater awareness among stakeholders.
